Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,758 | -41,157 | -27,108 | -13,300 | -51,862 |
| Depreciation Amortization | -215 | -163 | -106 | -66 | 325 |
| Accounts receivable | -58 | -133 | -13 | 307 | -130 |
| Accounts payable and accrued liabilities | -856 | 485 | 822 | 296 | -2,225 |
| Other Working Capital | -5,213 | -5,000 | -4,337 | -5,755 | -3,955 |
| Other Operating Activity | 9,434 | 5,700 | 3,440 | 2,135 | 10,988 |
| Operating Cash Flow | $-51,666 | $-40,268 | $-27,302 | $-16,383 | $-46,859 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 51,315 | 30,261 | 22,164 | 10,079 | -6,611 |
| PPE Investments | -390 | -269 | -243 | -204 | -428 |
| Investing Cash Flow | $50,925 | $29,992 | $21,921 | $9,875 | $-7,039 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 228 | 357 | 357 | 226 | 87,338 |
| Financing Cash Flow | $228 | $357 | $357 | $226 | $87,338 |
| Beginning Cash Position | 78,654 | 78,654 | 78,654 | 78,654 | 45,214 |
| End Cash Position | 78,141 | 68,735 | 73,630 | 72,372 | 78,654 |
| Net Cash Flow | $-513 | $-9,919 | $-5,024 | $-6,282 | $33,440 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,666 | -40,268 | -27,302 | -16,383 | -46,859 |
| Capital Expenditure | -390 | -269 | -243 | -204 | -428 |
| Free Cash Flow | -52,056 | -40,537 | -27,545 | -16,587 | -47,287 |